Press Release: FDA Approves Hetlioz: First Treatment for Non-24 Hour Sleep …

Published February 3, 2014

Press Release: FDA approves Hetlioz: first treatment for non-24 hour sleep …
"Non-24- hour sleep-wake disorder can prevent blind individuals from following the normal daily schedule that we all take for granted," said Eric Bastings, M.D, deputy director of the Division of Neurology Products in the FDA's Center for Drug … Read more on Wall Street Journal

Heroin deaths reinforce need for life-saving advice
Mixing stronger doses is a ploy by dealers, said Vanessa Sebetich, a spokeswoman for Greenbriar Treatment Center, which has locations in Pittsburgh's Squirrel Hill neighborhood and Washington County. “It does give street value to drugs,” Sebetich said. Read more on Tribune-Review

New Arizona rules would limits abortion drug use
The limits on using the drug mifepristone, commonly called RU-486, are the most problematic of the new rules, said Elizabeth Nash, state issues manager at the New York-based Guttmacher Institute, a pro-abortion rights research organization. “This would … Read more on Washington Post